During the past decade, Chatham-Kent Clinical Trials Research Centre conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 6 clinical trials were completed, i.e. on average, 60% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 3 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Chatham-Kent Clinical Trials Research Centre" #1 sponsor was "Boehringer Ingelheim" with 3 trials, followed by "Biohaven Pharmaceuticals, Inc." with 2 trials sponsored, "Shire" with 2 trials sponsored, "Assurex Health Inc." with 1 trials sponsored and "Janssen Pharmaceutica N.V., Belgium" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Chatham-Kent Clinical Trials Research Centre" #1 collaborator was "Assurex Health Ltd." with 1 trials as a collaborator, "Centre for Addiction and Mental Health" with 1 trials as a collaborator, "Genome Canada" with 1 trials as a collaborator, "Lundbeck Canada Inc." with 1 trials as a collaborator and "Mars Excellence in Clinical Innovation and Technology Evaluation" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Chatham-Kent Clinical Trials Research Centre" are "Major Depressive Disorder" (3 trials), "Depressive Disorder, Major" (2 trials), "Schizophrenia" (2 trials), "Alzheimer's Disease" (1 trials) and "Attention Deficit-Hyperactivity Disorder" (1 trials). Many other conditions were trialed in "Chatham-Kent Clinical Trials Research Centre" in a lesser frequency.

Most popular intervention types in "Chatham-Kent Clinical Trials Research Centre" are "Drug" (12 trials), "Other" (2 trials) and "Genetic" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "BI 409306" (2 trials), "BI 425809 dose 1" (1 trials), "BI 425809 dose 2" (1 trials) and "BI 425809 dose 3" (1 trials). Other intervention names were less common.

The vast majority of trials in "Chatham-Kent Clinical Trials Research Centre" are 13 trials for "All" genders.

Currently, there are NaN active trials in "Chatham-Kent Clinical Trials Research Centre". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 5 completed trials in Chatham-Kent Clinical Trials Research Centre, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Chatham-Kent Clinical Trials Research Centre, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 0 trials that are defined as “Not Applicable".